Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound ...

The fibroblast growth factor market presents opportunities in regenerative medicine, oncology, and metabolic disorders due to advances in molecular biology and delivery technologies. Key opportunities ...

RENSSELAER, N.Y.--(BUSINESS WIRE)--StemCultures, a life sciences company developing novel reagents that improve the quality and efficiency of cell growth and differentiation in culture, today ...

Rat sciatic nerve Schwann cells in culture respond to a limited range of mitogens, including glial growth factor, transforming growth factors beta-1 and beta-2 (TGF-β1, TGF-β2), some cell ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

FGF2 offers strategic growth opportunities in regenerative medicine and biopharmaceuticals, driven by advances in expression technologies and innovative delivery systems. Collaborative frameworks and ...

Researchers at Texas A&M University have uncovered a key element of joint cartilage regrowth, which brings them one step ...

An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...